Jayson Bedford
Stock Analyst at Raymond James
(3.85)
# 690
Out of 5,136 analysts
324
Total ratings
55.37%
Success rate
7.76%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $30.80 | -12.34% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $546.76 | +10.29% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $22.93 | -17.14% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $125.00 | +16.80% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $218.55 | -4.37% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $89.24 | +26.62% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $148.52 | +21.20% | 22 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $81.75 | +24.77% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $69.70 | +46.34% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $93.74 | +32.28% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $282.94 | +27.24% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $138.41 | +33.66% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $207.42 | +30.17% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $10.23 | -2.25% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $103.05 | +162.98% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $23.55 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $20.87 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $83.10 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.84 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $98.74 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.16 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $75.16 | +14.42% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.29 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.53 | - | 3 | Jan 2, 2018 |
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $30.80
Upside: -12.34%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $546.76
Upside: +10.29%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $22.93
Upside: -17.14%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $125.00
Upside: +16.80%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $218.55
Upside: -4.37%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $89.24
Upside: +26.62%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $148.52
Upside: +21.20%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $81.75
Upside: +24.77%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $69.70
Upside: +46.34%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $93.74
Upside: +32.28%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $282.94
Upside: +27.24%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $138.41
Upside: +33.66%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $207.42
Upside: +30.17%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $10.23
Upside: -2.25%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $103.05
Upside: +162.98%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $23.55
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $20.87
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $83.10
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $19.84
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $98.74
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $7.16
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $75.16
Upside: +14.42%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $2.29
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $12.53
Upside: -